TNBC researchers supported by Delaware INBRE
UD researchers chose to test their hypothesis on triple negative breast cancer (TNBC) because this subtype accounts for 15 to 20 percent of diagnosed breast cancer cases.
UD researchers chose to test their hypothesis on triple negative breast cancer (TNBC) because this subtype accounts for 15 to 20 percent of diagnosed breast cancer cases.
Delaware INBRE
15 Innovation Way
Newark, DE 19711, USA
info@de-inbre.org
302-831-4331
Supported by the NIH NIGMS IDeA
Program Grant #P20 GM103446